ABBOTT LABORATORIES·4

Feb 23, 8:38 PM ET

WOODGRIFT RANDEL WILLIAM 4

4 · ABBOTT LABORATORIES · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-18
WOODGRIFT RANDEL WILLIAM
Senior Vice President
Transactions
  • Award

    Common shares without par value

    2022-02-18+10,48254,225 total
  • Award

    Option (right to buy)

    2022-02-18+48,85248,852 total
    Exercise: $117.58From: 2023-02-18Exp: 2032-02-17Common Shares (48,852 underlying)
Holdings
  • Common shares without par value

    (indirect: By Trust)
    3,275
Footnotes (3)
  • [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
  • [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 18, 2022.
  • [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 16,284 on February 18, 2023, 16,284 on February 18, 2024, and 16,284 on February 18, 2025.

Documents

1 file
  • 4
    form4-02232022_050209.xmlPrimary